Skip to content
DataLookout
Menu

LeanMASLDNCT07451366

Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
    • Completed without a posted recruiting period
    • Primary completion date changed from estimate of Dec 1, 2026 to Jul 1, 2026
    • Study sites: 0 to 1
    • Study description revised
  2. Minor Study description shortened, about 17 words
    • Study title expanded, about 5 words
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Prevalence of Obesity and Clinical Characteristics of Lean MASLD Patients
Timeframe: 24 month

Sites

1 site in 1 country

  • Assiut UniversityAsyut, Egypt